Ian Mortimer
CIK 1619961 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 4, 2014 · Latest: Nov. 4, 2014
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
18 sells (S)
Net:
$-21,298,042
+ 50 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
50 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | XENE | S 10b5-1 | 7,308 | $55.22 | $403,548 | 19,923 Direct | -26.84% | Disposed | 15.8% (price as of 2026-08-19) |
| March 10, 2026 | XENE | S 10b5-1 | 11,269 | $60.11 | $677,380 | 14,731 Direct | -43.34% | Disposed | 6.4% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 65,000 | $62.06 | $4,033,900 | 6,000 Direct | -91.55% | Disposed | 3.0% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 61,652 | $60.08 | $3,704,052 | 6,000 Direct | -91.13% | Disposed | 6.4% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 43,348 | $59.26 | $2,568,802 | 72,652 Direct | -37.37% | Disposed | 7.9% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 2,449 | $61.26 | $150,026 | 6,000 Direct | -28.99% | Disposed | 4.4% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 10,072 | $60.47 | $609,054 | 8,449 Direct | -54.38% | Disposed | 5.8% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 12,479 | $59.50 | $742,500 | 18,521 Direct | -40.25% | Disposed | 7.5% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 21,515 | $60.49 | $1,301,442 | 6,000 Direct | -78.19% | Disposed | 5.7% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 31,694 | $59.88 | $1,897,837 | 27,515 Direct | -53.53% | Disposed | 6.8% (price as of 2026-08-19) |
| March 9, 2026 | XENE | S 10b5-1 | 21,791 | $58.81 | $1,281,529 | 59,209 Direct | -26.90% | Disposed | 8.7% (price as of 2026-08-19) |
| Jan. 2, 2026 | XENE | S 10b5-1 | 2,062 | $44.93 | $92,646 | 6,000 Direct | -25.58% | Disposed | 42.3% (price as of 2026-08-19) |
| Jan. 2, 2026 | XENE | S 10b5-1 | 37,938 | $44.40 | $1,684,447 | 8,062 Direct | -82.47% | Disposed | 44.0% (price as of 2026-08-19) |
| Dec. 8, 2025 | XENE | S 10b5-1 | 2,010 | $46.32 | $93,103 | 6,000 Direct | -25.09% | Disposed | 38.1% (price as of 2026-08-19) |
| Dec. 8, 2025 | XENE | S 10b5-1 | 8,820 | $45.59 | $402,104 | 8,010 Direct | -52.41% | Disposed | 40.3% (price as of 2026-08-19) |
| Dec. 5, 2025 | XENE | S 10b5-1 | 14,375 | $45.03 | $647,306 | 16,830 Direct | -46.07% | Disposed | 42.0% (price as of 2026-08-19) |
| Nov. 28, 2025 | XENE | S 10b5-1 | 97 | $45.01 | $4,366 | 31,205 Direct | -0.31% | Disposed | 42.1% (price as of 2026-08-19) |
| Oct. 1, 2025 | XENE | S 10b5-1 | 25,000 | $40.16 | $1,004,000 | 31,302 Direct | -44.40% | Disposed | 59.2% (price as of 2026-08-19) |
| Jan. 27, 2025 | XENE | S 10b5-1 | 1,149 | $41.07 | $47,189 | 31,302 Direct | -3.54% | Disposed | 55.7% (price as of 2026-08-19) |
| Jan. 27, 2025 | XENE | S 10b5-1 | 15,166 | $40.46 | $613,616 | 31,302 Direct | -32.64% | Disposed | 58.1% (price as of 2026-08-19) |
| Jan. 24, 2025 | XENE | S 10b5-1 | 22,468 | $40.20 | $903,214 | 31,302 Direct | -41.79% | Disposed | 59.1% (price as of 2026-08-19) |
| Jan. 23, 2025 | XENE | S 10b5-1 | 16,217 | $40.08 | $649,977 | 31,302 Direct | -34.13% | Disposed | 59.6% (price as of 2026-08-19) |
| May 24, 2023 | XENE | S | 1,407 | $41.49 | $58,376 | 31,302 Direct | -4.30% | Disposed | 54.1% (price as of 2026-08-19) |
| May 24, 2023 | XENE | S | 13,179 | $41.37 | $545,215 | 27,708 Direct | -32.23% | Disposed | 54.6% (price as of 2026-08-19) |
| May 24, 2023 | XENE | S | 17,069 | $41.44 | $707,339 | 24,213 Direct | -41.35% | Disposed | 54.3% (price as of 2026-08-19) |
| Aug. 10, 2017 | XENE | P | 10,000 | $2.90 | $29,000 | 14,300 Indirect | +232.56% | Acquired | 2105.2% (price as of 2026-08-19) |
| Aug. 10, 2017 | XENE | P | 5,000 | $2.84 | $14,200 | 6,000 Direct | +500.00% | Acquired | 2151.8% (price as of 2026-08-19) |
| June 24, 2016 | XENE | P | 1,300 | $6.30 | $8,190 | 4,300 Indirect | +43.33% | Acquired | 915.1% (price as of 2026-08-19) |
| June 24, 2016 | XENE | P | 2,000 | $6.25 | $12,500 | 3,000 Indirect | +200.00% | Acquired | 923.2% (price as of 2026-08-19) |
| June 24, 2016 | XENE | P | 1,000 | $6.10 | $6,100 | 1,000 Indirect | — | Acquired | 948.4% (price as of 2026-08-19) |
| June 24, 2016 | XENE | P | 1,000 | $6.15 | $6,150 | 1,000 Direct | — | Acquired | 939.8% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 12, 2026 | XENE | Restricted Share Units | Common Shares (12,500) | — | — | 12,500 | Disposed |
| March 9, 2026 | XENE | Performance Share Units | Common Shares (20,000) | — | — | 20,000 | Disposed |
| March 9, 2026 | XENE | Performance Share Units | Common Shares (20,000) | — | — | 20,000 | Acquired |
| March 9, 2026 | XENE | Stock Option | Common Shares (65,000) | $9.44 | Sept. 15, 2029 | 65,000 | Disposed |
| March 9, 2026 | XENE | Stock Option | Common Shares (105,000) | $4.75 | March 11, 2028 | 105,000 | Disposed |
| March 9, 2026 | XENE | Stock Option | Common Shares (25,000) | $3.10 | Oct. 22, 2027 | 25,000 | Disposed |
| March 9, 2026 | XENE | Stock Option | Common Shares (75,000) | $8.40 | March 12, 2027 | 75,000 | Disposed |
| Jan. 9, 2026 | XENE | Restricted Share Units | Common Shares (65,000) | $0.00 | — | 65,000 | Acquired |
| Jan. 9, 2026 | XENE | Share Option (Right to Buy) | Common Shares (350,000) | $42.15 | Jan. 8, 2036 | 350,000 | Acquired |
| Jan. 2, 2026 | XENE | Stock Option (Right to Buy) | Common Shares (40,000) | $7.49 | March 10, 2026 | 40,000 | Disposed |
| Oct. 1, 2025 | XENE | Stock Option (Right to Buy) | Common Shares (25,000) | $7.69 | Dec. 17, 2025 | 25,000 | Disposed |
| March 12, 2025 | XENE | Restricted Share Units | Common Shares (50,000) | $0.00 | — | 50,000 | Acquired |
| March 12, 2025 | XENE | Share Option (Right to Buy) | Common Shares (275,000) | $35.48 | March 11, 2035 | 275,000 | Acquired |
| Jan. 27, 2025 | XENE | Stock Option (Right to Buy) | Common Shares (16,315) | $17.76 | March 16, 2025 | 16,315 | Disposed |
| Jan. 24, 2025 | XENE | Stock Option (Right to Buy) | Common Shares (22,468) | $17.76 | March 16, 2025 | 22,468 | Disposed |
| Jan. 23, 2025 | XENE | Stock Option (Right to Buy) | Common Shares (16,217) | $17.76 | March 16, 2025 | 16,217 | Disposed |
| March 11, 2024 | XENE | Stock Option (Right to Buy) | Common Shares (250,000) | $44.37 | March 10, 2034 | 250,000 | Acquired |
| May 24, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (6,172) | — | Jan. 13, 2024 | 6,172 | Disposed |
| May 24, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (20,576) | — | Jan. 13, 2024 | 20,576 | Disposed |
| May 24, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (42,592) | — | July 31, 2023 | 42,592 | Disposed |
| March 10, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (380,000) | $34.18 | March 9, 2033 | 380,000 | Acquired |
| March 10, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (400,000) | $30.01 | March 9, 2032 | 400,000 | Acquired |
| June 3, 2021 | XENE | Stock Option (Right to Buy) | Common Shares (125,000) | $18.56 | June 2, 2031 | 125,000 | Acquired |
| March 12, 2021 | XENE | Stock Option (Right to Buy) | Common Shares (100,000) | $20.55 | March 11, 2031 | 100,000 | Acquired |
| March 12, 2020 | XENE | Stock Option (Right to Buy) | Common Shares (145,000) | $11.58 | March 11, 2030 | 145,000 | Acquired |
| Sept. 16, 2019 | XENE | Stock Option (Right to Buy) | Common Shares (135,000) | $9.44 | Sept. 15, 2029 | 135,000 | Acquired |
| March 12, 2018 | XENE | Stock Option (Right to Buy) | Common Shares (105,000) | $4.75 | March 11, 2028 | 105,000 | Acquired |
| Oct. 23, 2017 | XENE | Stock Option (Right to Buy) | Common Shares (25,000) | $3.10 | Oct. 22, 2027 | 25,000 | Acquired |
| March 13, 2017 | XENE | Stock Option (Right to Buy) | Common Shares (75,000) | $8.40 | March 12, 2027 | 75,000 | Acquired |
| March 11, 2016 | XENE | Stock Option (Right to Buy) | Common Shares (40,000) | $7.49 | March 10, 2026 | 40,000 | Acquired |
| Dec. 18, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (25,000) | $7.69 | Dec. 17, 2025 | 25,000 | Acquired |
| March 17, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (55,000) | $17.76 | March 16, 2025 | 55,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $281,763 | — | — | — | $112,705 | — | $17,252 | $587,822 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.